BACKGROUND/AIMS: Thirty-four patients with portal hypertension and previous history of esophageal varices hemorrhage due to hepatosplenic Mansonic schistosomiasis were prospectively studied. METHODOLOGY: All patients underwent invasive hemodynamic monitoring with introduction of a pulmonary artery catheter. Hemodynamic evaluation was characterized by an increased cardiac index (4.90 +/- 1.27 L/min/m2) associated to a decrease in systemic vascular resistance index (1461 +/- 443.04 dynes.sec/cm5.m2). RESULTS: Mean pulmonary artery pressure (17.97 +/- 6.97 mmHg) and right atrial pressure (7.65 +/- 3.67 mmHg) were increased while pulmonary vascular resistance index was decreased (147.95 +/- 126.21 dynes.sec/cm5.m2). Twenty-four patients (70.5%) presented pulmonary hypertension (mean pulmonary artery pressure > 15 mmHg); in fifteen (44.1%) pulmonary pressure was between 15 and 20 mmHg, in three between 20 and 25 mmHg and, in four patients, pulmonary pressure was higher than 25 mmHg. CONCLUSIONS: In conclusion, pulmonary hypertension is a frequent complication in patients with portal hypertension due to hepatosplenic Mansonic schistosomiasis and, in 20.6% of the cases, it can be considered as moderate or severe. Our results suggest that shunt surgeries, which can aggravate pulmonary hypertension, should be employed very cautiously in the treatment of schistosomal portal hypertension.
BACKGROUND/AIMS: Thirty-four patients with portal hypertension and previous history of esophageal varices hemorrhage due to hepatosplenic Mansonic schistosomiasis were prospectively studied. METHODOLOGY: All patients underwent invasive hemodynamic monitoring with introduction of a pulmonary artery catheter. Hemodynamic evaluation was characterized by an increased cardiac index (4.90 +/- 1.27 L/min/m2) associated to a decrease in systemic vascular resistance index (1461 +/- 443.04 dynes.sec/cm5.m2). RESULTS: Mean pulmonary artery pressure (17.97 +/- 6.97 mmHg) and right atrial pressure (7.65 +/- 3.67 mmHg) were increased while pulmonary vascular resistance index was decreased (147.95 +/- 126.21 dynes.sec/cm5.m2). Twenty-four patients (70.5%) presented pulmonary hypertension (mean pulmonary artery pressure > 15 mmHg); in fifteen (44.1%) pulmonary pressure was between 15 and 20 mmHg, in three between 20 and 25 mmHg and, in four patients, pulmonary pressure was higher than 25 mmHg. CONCLUSIONS: In conclusion, pulmonary hypertension is a frequent complication in patients with portal hypertension due to hepatosplenic Mansonic schistosomiasis and, in 20.6% of the cases, it can be considered as moderate or severe. Our results suggest that shunt surgeries, which can aggravate pulmonary hypertension, should be employed very cautiously in the treatment of schistosomal portal hypertension.
Authors: Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi Journal: Clin Microbiol Rev Date: 2010-04 Impact factor: 26.132
Authors: Anastasia Anthi; Roberto F Machado; Maria L Jison; Angelo M Taveira-Dasilva; Lewis J Rubin; Lori Hunter; Christian J Hunter; Wynona Coles; James Nichols; Nilo A Avila; Vandana Sachdev; Clara C Chen; Mark T Gladwin Journal: Am J Respir Crit Care Med Date: 2007-03-22 Impact factor: 21.405
Authors: Fabricio Ferreira Coelho; Marcos Vinícius Perini; Jaime Arthur Pirola Kruger; Gilton Marques Fonseca; Raphael Leonardo Cunha de Araújo; Fábio Ferrari Makdissi; Renato Micelli Lupinacci; Paulo Herman Journal: Arq Bras Cir Dig Date: 2014 Apr-Jun
Authors: Jacob J Chabon; Liya Gebreab; Rahul Kumar; Elias Debella; Takeshi Tanaka; Dan Koyanagi; Alexandra Rodriguez Garcia; Linda Sanders; Mario Perez; Rubin M Tuder; Brian B Graham Journal: Pulm Circ Date: 2014-06 Impact factor: 3.017
Authors: Brian B Graham; Jacob Chabon; Rahul Kumar; Ewa Kolosionek; Liya Gebreab; Elias Debella; Michael Edwards; Katrina Diener; Ted Shade; Gao Bifeng; Angela Bandeira; Ghazwan Butrous; Kenneth Jones; Mark Geraci; Rubin M Tuder Journal: Am J Respir Cell Mol Biol Date: 2013-12 Impact factor: 6.914
Authors: Carlos Franco-Paredes; Nadine Rouphael; José Méndez; Erik Folch; Alfonso J Rodríguez-Morales; José Ignacio Santos; J W Hurst Journal: Clin Cardiol Date: 2007-06 Impact factor: 2.882
Authors: Roberto de Cleva; Paulo Herman; Luis Augusto Carneiro D'albuquerque; Vincenzo Pugliese; Orlando Luis Santarem; William Abrão Saad Journal: World J Gastroenterol Date: 2007-11-07 Impact factor: 5.742
Authors: Zakari Y Aliyu; Victor Gordeuk; Vandana Sachdev; Aliyu Babadoko; Aisha I Mamman; Peter Akpanpe; Ester Attah; Yusuf Suleiman; Nurudeen Aliyu; Jamilu Yusuf; Laurel Mendelsohn; Gregory J Kato; Mark T Gladwin Journal: Am J Hematol Date: 2008-06 Impact factor: 10.047